INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
Public company

PRLDPrelude Therapeutics Inc

CIK 0001678660

EDGAR filingsOpen in network
Disclosed transactions3
Buys / sells0 / 0
Max Insider Score9
Connections4with evidence

PRLD · disclosed activity on price

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
VK
Vaddi KrishnaDirector, CEO
PRLDPrelude Therapeutics Inc
Grant or award
A—
837.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • In industryevidence
    Pharmaceuticals, devices & health servicesSEC SIC 2834 · Pharmaceutical Preparations · Nov 5, 2026
  • ← Insider ofevidence
    Vaddi KrishnaDirector, CEO · Feb 5, 2026
  • ← Insider ofevidence
    Combs AndrewChief Chemistry Officer · Feb 5, 2026
  • ← Insider ofevidence
    Scherle PeggyChief Scientific Officer · Feb 5, 2026
9
CA
Combs AndrewChief Chemistry Officer
PRLDPrelude Therapeutics Inc
Grant or award
A
—
230.0K sh
Feb 4, 2026
Feb 5, 2026
traded Feb 4, 2026
+1d
SEC FORM 4

Evidence

9
SP
Scherle PeggyChief Scientific Officer
PRLDPrelude Therapeutics Inc
Grant or award
A—
230.0K sh
Feb 4, 2026Feb 5, 2026
traded Feb 4, 2026
+1dSEC FORM 4

Evidence